| Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer (NCT02499146) | Pfizer | 2015-09-11 |
| TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors (NCT02574663) | TG Therapeutics, Inc. | 2015-09-11 |
| Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies (NCT02457559) | Gilead Sciences | 2015-09-10 |
| A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma (NCT02512900) | MedImmune LLC | 2015-09-10 |
| Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects (NCT02490787) | Novo Nordisk A/S | 2015-09-10 |
| Donation of Whole Blood by Healthy Volunteers After Mobilisation by Haematopoietic Growth Factor (Rhu-G-CSF = Granocyte) (NCT05594433) | CellProthera | 2015-09-10 |
| Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects (NCT02578953) | GlaxoSmithKline | 2015-09-09 |
| IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers (NCT03457649) | argenx | 2015-09-09 |
| VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer (NCT02371447) | Swiss Cancer Institute | 2015-09-08 |
| Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers (NCT02526017) | Five Prime Therapeutics, Inc. | 2015-09-08 |
| A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects (NCT04466748) | Sihuan Pharmaceutical Holdings Group Ltd. | 2015-09-08 |
| Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance (NCT03383822) | University Health Network, Toronto | 2015-09-08 |
| Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy (NCT02551003) | Children's Hospital of Fudan University | 2015-09-08 |
| Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery (NCT02540876) | University of Chicago | 2015-09-08 |
| Testing the Addition of the Anti-Cancer Drug Talazoparib to the Combination of Carboplatin and Paclitaxel for the Treatment of Advanced Cancer (NCT02317874) | National Cancer Institute (NCI) | 2015-09-08 |
| A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI) (NCT02495233) | Astellas Pharma Global Development, Inc. | 2015-09-08 |
| Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097) (NCT02452034) | Merck Sharp & Dohme LLC | 2015-09-07 |
| Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin (NCT02783040) | Boehringer Ingelheim | 2015-09-07 |
| Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects (NCT02513654) | GlaxoSmithKline | 2015-09-06 |
| Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects (NCT02502812) | GlaxoSmithKline | 2015-09-04 |
| Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant (NCT02485535) | University of Chicago | 2015-09-04 |
| A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC (NCT02451930) | Eli Lilly and Company | 2015-09-04 |
| Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines (NCT02432378) | Roswell Park Cancer Institute | 2015-09-04 |
| Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects (NCT02699710) | Genentech, Inc. | 2015-09-03 |
| CART-BCMA Cells for Multiple Myeloma (NCT02546167) | University of Pennsylvania | 2015-09-03 |
| Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896) | University of Southern California | 2015-09-03 |
| Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors (NCT02736500) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2015-09-02 |
| 8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02509546) | City of Hope Medical Center | 2015-09-02 |
| A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NHL) (NCT02509039) | Celgene | 2015-09-02 |
| Medication-Assisted Treatment for Youth With Substance Use Disorders (NCT02593474) | New York State Psychiatric Institute | 2015-09-01 |
| Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers (NCT02631954) | Chong Kun Dang Pharmaceutical | 2015-09-01 |
| Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475 (NCT02303366) | Peter MacCallum Cancer Centre, Australia | 2015-09-01 |
| A Pharmacokinetics Study of Intravenous Ascorbic Acid (NCT02534753) | McGuff Pharmaceuticals, Inc. | 2015-09-01 |
| A Study Evaluating Biomarkers in Participants With Heart Failure (MK-0000-344) (NCT02364752) | Merck Sharp & Dohme LLC | 2015-09-01 |
| Levetiracetam Treatment of Neonatal Seizures (NCT02550028) | Children's Hospital of Fudan University | 2015-09-01 |
| A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer (NCT02507544) | TaiRx, Inc. | 2015-09-01 |
| A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients (NCT02524444) | ORIYOMI OMOTOYOSI AKINYOTU | 2015-09-01 |
| Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution (NCT02773316) | Mundipharma Research Limited | 2015-09-01 |
| Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors (NCT02564900) | Daiichi Sankyo Co., Ltd. | 2015-09-01 |
| A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog® (NCT02562313) | Adocia | 2015-09-01 |
| Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078 (NCT02567773) | GlaxoSmithKline | 2015-09-01 |
| Improving Functional Outcomes of Veterans With PTSD and Tobacco Dependence (NCT02576899) | VA Office of Research and Development | 2015-09-01 |
| Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy (NCT02733393) | NYU Langone Health | 2015-09-01 |
| Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella (NCT02196285) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2015-09-01 |
| Effect of Dose of Buglossoides Oil on EPA Accrual and on the Inflammatory Response (NCT02540759) | Réseau de Santé Vitalité Health Network | 2015-09-01 |
| Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds. (NCT02782702) | University Hospital, Toulouse | 2015-09-01 |
| Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints (NCT02394730) | Kirby Institute | 2015-09-01 |
| A Phase I, Open Interaction Study Between GLPG1837 and Midazolam in Healthy Male Subjects (NCT02562950) | Lakefront Biotherapeutics NV | 2015-09-01 |
| Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin (NCT02592954) | Johns Hopkins University | 2015-09-01 |
| Tolerability and Pharmacokinetic Study of Econazole Nitrate and Benzydamine HCl Intravaginal Cream (NCT02713893) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2015-09-01 |
| Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer (NCT02480374) | Imunon | 2015-09-01 |
| Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation (NCT03182413) | Theranexus | 2015-09-01 |
| To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%) (NCT02847286) | International Partnership for Microbicides, Inc. | 2015-09-01 |
| myDC/pDC in Stage III Melanoma Patients (NCT02574377) | Radboud University Medical Center | 2015-09-01 |
| Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis (NCT02566655) | Red de Terapia Celular | 2015-09-01 |
| Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers (NCT02529800) | Hanmi Pharmaceutical Company Limited | 2015-09-01 |
| A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants (NCT02543918) | Eli Lilly and Company | 2015-09-01 |
| Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans (NCT02537314) | Vanderbilt University Medical Center | 2015-09-01 |
| Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP) (NCT02868060) | Kyowa Kirin China Pharmaceutical Co., Ltd. | 2015-09-01 |
| Single Dose Study of PF-05230907 in Healthy Japanese Subjects (NCT02537002) | Pfizer | 2015-09-01 |
| Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism (NCT02552147) | Yale University | 2015-09-01 |
| Safety, Blood Levels and Effects of AUT00206 (NCT02589262) | Autifony Therapeutics Limited | 2015-09-01 |
| A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects (NCT02567695) | Global Blood Therapeutics | 2015-09-01 |
| A Study of LY3076226 in Participants With Advanced or Metastatic Cancer (NCT02529553) | Eli Lilly and Company | 2015-09-01 |
| Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C) (NCT02313857) | AlloVir | 2015-09-01 |
| Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer (NCT02536495) | Erin Bertino | 2015-09-01 |
| A Study Comparing Amounts of Tafamidis In The Blood With Or Without Food (NCT02534740) | Pfizer | 2015-09-01 |
| Low Field Magnetic Stimulation: Open Label Study. (NCT02542475) | Mclean Hospital | 2015-09-01 |
| Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma (NCT02507583) | david andrews | 2015-09-01 |
| A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients (NCT02492789) | Atridia Pty Ltd. | 2015-09-01 |
| MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection (NCT02532036) | University of Oxford | 2015-09-01 |
| Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation (NCT02564354) | ProQR Therapeutics | 2015-09-01 |
| Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B (NCT02283671) | Sara Varea | 2015-09-01 |
| A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma (NCT02550678) | Ascend Biopharmaceuticals Ltd | 2015-09-01 |
| Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD (NCT02616731) | Ain Shams University | 2015-09-01 |
| Intravenous Clonidine for Sedation in Infants and Children Who Are Mechanically Ventilated - Dosing Finding Study (NCT02249039) | Johns Hopkins University | 2015-09-01 |
| Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes (NCT02579148) | Leilei Zhu | 2015-09-01 |
| Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis (NCT02566681) | Red de Terapia Celular | 2015-09-01 |
| Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer (NCT02358161) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-09-01 |
| Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma (NCT02567656) | Rhizen Pharmaceuticals SA | 2015-09-01 |
| Safety Study of CNT-01 in Patients With Idiopathic TGCV (NCT02502578) | Osaka University | 2015-09-01 |
| Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation (NCT02417870) | Anil K. Chandraker, MD | 2015-09-01 |
| A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers (NCT02535416) | Arrowhead Pharmaceuticals | 2015-09-01 |
| A First Time in Human Study in Healthy Volunteers and Patients (NCT03010787) | VHsquared Ltd. | 2015-09-01 |
| A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients (NCT02550535) | Cell Medica Ltd | 2015-09-01 |
| Efficacy of Pregabalin on Chronic Cough (NCT02482818) | Ottawa Hospital Research Institute | 2015-09-01 |
| PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers (NCT02553356) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-09-01 |
| A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer (NCT02483247) | Sumitomo Pharma America, Inc. | 2015-09-01 |
| Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma (NCT02569788) | Shanghai Proton and Heavy Ion Center | 2015-09-01 |
| A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin (NCT02569814) | Boryung Pharmaceutical Co., Ltd | 2015-09-01 |
| A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense (NCT02849249) | Roxall Medicina España S.A | 2015-09-01 |
| Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC (NCT02531425) | OncoSec Medical Incorporated | 2015-09-01 |
| Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke (NCT02586233) | Daiichi Sankyo | 2015-09-01 |
| PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP (NCT02401061) | Protalex, Inc. | 2015-09-01 |
| Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC (NCT03780010) | Tracon Pharmaceuticals Inc. | 2015-09-01 |
| CV004-007 Thrombosis Chamber Study (NCT02439190) | Bristol-Myers Squibb | 2015-09-01 |
| A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT02521870) | Dynavax Technologies Corporation | 2015-09-01 |
| Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer (NCT02437370) | University of California, Davis | 2015-09-01 |
| Characterizing the Specificity and Stability of Local Field Potentials in the Globus Pallidus Internus of Patients Undergoing Deep Brain Stimulation for Parkinson's Disease (NCT02438033) | Nader Pouratian | 2015-09-01 |
| Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets (NCT02522208) | Arbor Pharmaceuticals, Inc. | 2015-09-01 |